The EPA’s Inspector General Is Probing Whether An Agency

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
265
The EPA’s Inspector General Is Probing Whether An Agency Staffer Colluded With Monsanto

http://www.huffingtonpost.com/entry/epa-inspe...mg00000004

The investigation comes in response to documents released in a court case over whether the herbicide glyphosate causes cancer.

he inspector general for the Environmental Protection Agency is initiating a probe into possible collusion between a former high-ranking EPA official and Monsanto, the maker of the herbicide glyphosate, according to a letter the IG sent to a lawmaker last Friday that HuffPost has obtained.

The inspector general’s move comes in response to a request from Rep. Ted Lieu (D-Calif.) for an investigation into whether the EPA staffer colluded with the agricultural giant to bias research on glyphosate, a key component of the product Roundup. His request was based on media reports of documents released in the course of a lawsuit against Monsanto alleging glyphosate causes cancer, and that the company may have spun research and hired scientists to cover this up.

“As you are aware, there is considerable public interest regarding allegations of such collusion,” wrote Inspector General Arthur A. Elkins Jr. in his response to Lieu, dated May 31. “As a result, I have asked the EPA OIG Office of Investigations to conduct an inquiry into several agency review-related matters.”

The EPA and Lieu did not immediately return requests for comment for this story.

Documents released in the lawsuit reference internal Monsanto emails mentioning Jess Rowland, who was previously a manager in the EPA’s pesticide division, allegedly bragging to company officials in April 2015 that he could “kill” investigations into glyphosate. A Monsanto regulatory affairs manager sent an email to colleagues that said Rowland had told him, “If I can kill this I should get a medal.”

At the time of the email, Monsanto was apparently seeking Rowland’s help to shut down a review of glyphosate within the Agency for Toxic Substances and Disease Registry, a division of the U.S. Department of Health and Human Services.

Rowland retired from the EPA last year, and plaintiffs’ lawyers have been deposing him about allegations that Monsanto may have funneled money to him through third parties.

Rowland’s lawyer, William E. Lawler III, downplayed the IG’s letter in an email to HuffPost. “Jess Rowland is a well-respected former public servant who honorably served the EPA for 26 years and received commendations from the agency both during his service and on his retirement,” wrote Lawler. “He is a man of the highest integrity and ethics and he has done nothing wrong.”

Monsanto did not respond to multiple requests for comment.

Inspectors general have wide-ranging authority to investigate matters of corruption at federal agencies, explains Michael Hubbard, a retired Special Agent in Charge for the EPA’s criminal investigations division.

With confirmation that the IG’s office is taking up a probe, it’s likely that IG investigators will begin interviewing Rowland’s former colleagues and bosses, pulling records and looking through his emails, Hubbard said. Another step could involve looping in investigators at the Department of Justice’s Public Integrity Section, or obtaining subpoenas that would grant access to Rowland’s bank records.

“You want to start looking at money trails,” Hubbard said. “Has he benefited from Monsanto? Was the money changing hands with him or his significant other?”

The court cases against Monsanto have rippled across the Atlantic, sparking debate in Europe, where governments are considering whether to renew an application allowing glyphosate to stay on the market in the European Union, said Bart Staes, a Belgian member of parliament representing the Green Party.

“There has been a political and scientific debate for the last two years because the authorization to bring glyphosate to the market has expired and we need to make a decision by the end of the year,” said Staes.

The International Agency for Research on Cancer, the World Health Organization division focused on cancer, issued a conclusion in March 2015 that glyphosate is carcinogenic. But the European Food Safety Authority, an EU scientific body evaluating food-related concerns, issued its own finding in October 2015 that it was not. The two rely on different criteria to come to their decision, Staes said: While IARC relies on published studies, EFSA is also able to assess data that is proprietary to companies.

Last week, Christopher Portier, the former associate director of the National Institute of Environmental Health Sciences, sent a letter to the president of the European Commission stating that he had re-examined some raw data of animal studies EFSA used to conclude that glyphosate did not cause cancer, and found eight instances of tumors that EFSA had not included in its assessment. Portier recently retired after 40 years of employment in the United States government and is now a part-time adviser to the Environmental Defense Fund and a consultant to a law firm involved in glyphosate litigation.

Members of the EU Parliament had asked him to review a portion of the proprietary data EFSA released to them, though he is not allowed to make that data more widely available, he said. “The lawyers back in the States haven’t seen this,” Portier told HuffPost.

Portier, who added that he wasn’t compensated for this work, said he is going to write to the EPA administrator himself because “they also missed all the tumors.”

“They have had this information in their files for decades, but they never analyzed the data,” he told HuffPost.

The head of IARC recently told Politico that his organization has faced an onslaught of criticism regarding its conclusions on glyphosate similar to backlash IARC faced from tobacco companies in the early 2000s when it concluded that secondhand smoke causes cancer.

Staes said the glyphosate lawsuit in the U.S. has spurred further concern that Monsanto has colluded with purportedly independent scientists: “We are now getting some written proof of collusion between scientists and Monsanto, which has these scientists like puppets on a string.”

Following Portier’s letter, Staes and three other members of parliament filed a lawsuit demanding that EFSA make all the data on glyphosate public.

“More and more, the debate is about corporations controlling the science, and then this science is used by the regulators,” said Staes. “This really goes beyond glyphosate.”
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bloomberg Tax Celebrates Global Tax Leaders at IFA

Updated Category News Views 50

Spotlight on Global Tax Leadership Here's a twist for you: tax law may not scream excitement, but when international tax changemakers get recognized, even the unflappable have to nod in appreciation. Bloomberg Tax just tossed accolades at five distinguished authors who are mapping the complexities of international tax landscapes. This isn't just about numbers—it's...

Continue Reading
Lincoln Educational Faces Class Action for Stock Drop

Updated Category News Views 68

What's Gripping Lincoln Educational Services? You ever feel like you've stepped into a financial thriller with these education stocks? Well, Lincoln Educational Services (NASDAQ:LINC) is at the heart of one, facing the heat of a class action lawsuit filed by Bleichmar Fonti & Auld LLP. It's all about securities fraud—a dreaded term that no investor wants to hear. The...

Continue Reading
Ad Council Expands Board, Taps Meta Exec as Vice Chair

Updated Category News Views 114

An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...

Continue Reading
FIU Cuba Poll: Cuban American Vote Leans GOP

Updated Category News Views 44

Here we got the latest scoop from the 2026 FIU Cuba Poll, and boy, it's a wild ride. Picture this: 76% of Cuban Americans in South Florida aren't fans of Trump’s escalated deportations of Cubans sans criminal records, yet a solid 68% are sticking to their GOP guns come election season. Now, ain't that a head-scratcher? Cuban Americans and the GOP: A Complex Relationship...

Continue Reading
Ferrovial's 2026 Growth: North America Drives Success

Updated Category News Views 6

Solid Gains Across the Board Right off the bat, Ferrovial's 2026 report card screams 'win'. For the first three quarters, they clocked in a hefty 21.8% boost in adjusted EBITDA, and revenue didn't dawdle either, climbing 10.8%—not exactly a stroll in the park to accomplish. North America's No Joke Ferrovial's got a clear hero in their narrative and it's North America....

Continue Reading
Fairfax Crest: A New Chapter in Affordable Housing

Updated Category News Views 52

Setting the Stage: Fairfax Crest's Grand Opening You know what's better than leaving a dusty old car park underutilized? Turning it into homes for folks who really need them. That's exactly what went down in Fairfax County as they cut the ribbon on their latest affordable housing project, Fairfax Crest. We're talking 279 affordable units sprouting up where there once lay...

Continue Reading
Antibiotic Overuse for Sinus Infections Costs Billions

Updated Category News Views 45

Sinus Infections: A Case of Excess Prescriptions You'd think with all the guidelines, doctors would've nailed the sinusitis treatment by now. But nope—antibiotic overuse remains alive and kicking. A fresh dig from Motive Medical Intelligence shows that more than three-quarters of primary care clinicians are quick to hand out antibiotics for acute sinusitis. So here we...

Continue Reading
Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Updated Category News Views 55

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...

Continue Reading
UP Fintech Faces Class Action Over Alleged Misconduct

Updated Category News Views 36

UP Fintech: A Financial Storm Brews When it rains, it sure pours. Investors are finding themselves stuck in the middle of a squall as UP Fintech Holding Limited's legal troubles unfold. Robbins LLP, a shareholder rights law firm, has filed a class-action lawsuit targeting UP Fintech (NASDAQ:TIGR), and the lawsuit isn't just some casual fling—it digs deep into the...

Continue Reading
San Diego's Iconic Nightlife Venue Revives as The Quin

Updated Category News Views 90

The ghosts of PLUXX's past are getting a new home at The Quin in San Diego. It's happening in the Gaslamp Quarter, where the familiar pulse of a party will hit the scene once again. Instead of peeling walls and the typical downtown club smell, we've got internationally acclaimed DJ Sam Feldt headlining the Halloween bash—Heaven & Hell. The Quin's Next Chapter Begins on...

Continue Reading

Top 5 Most Recently Viewed Articles

Coinbase to Reveal Financial Performance at Upcoming Event

Updated Category News Views 116

Coinbase Financial Results Announcement Coinbase Global, Inc. is gearing up to present its fourth quarter and full year 2024 results. The highly anticipated shareholder letter will be made available on the company’s Investor Relations website. Investors can expect to find comprehensive financial data and insights that reflect the company’s commitment to transparency...

Continue Reading
Kamada Secures $25 Million Supply Agreement for KAMRAB® and VARIZIG®

Updated Category News Views 265

Kamada Secures Major Supply Agreement in Latin America REHOVOT, Israel and HOBOKEN, N.J. – Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global leader in biopharmaceuticals with a renowned portfolio aimed at rare and serious conditions, proudly announces its latest achievement: securing a contract with an influential international organization. Contract Overview This...

Continue Reading
Key Developments on Owlet's Stockholder Derivative Settlement

Updated Category News Views 317

Overview of the Proposed Settlement for Owlet, Inc. Owlet, Inc. (NYSE: OWLT) recently issued a significant notice concerning a proposed settlement in a shareholder derivative lawsuit. This comes as part of a consolidated action that addresses alleged issues raised by shareholders regarding company governance. Details of the Derivative Action The derivative lawsuit,...

Continue Reading
Amcor and Cofigeo Collaborate on Innovative Meal Tray Design

Updated Category News Views 168

Amcor and Cofigeo Collaborate for Sustainable Meal Packaging Amcor, renowned for its commitment to responsible packaging solutions, has recently joined forces with Cofigeo to introduce a groundbreaking multi-compartment tray aimed at improving convenience and sustainability in meal packaging. This collaboration reflects the increasing demand for environmentally friendly...

Continue Reading
MarineMax, Inc. Faces Fraud Investigation: Key Insights for Investors

Updated Category News Views 178

Understanding MarineMax's Recent Challenges MarineMax, Inc. is a prominent name in the recreational marine industry. Recently, the Company has come under scrutiny due to potential securities law violations. This investigation, led by advocates for shareholders, particularly focuses on the allegations that MarineMax misrepresented financial conditions and failed to...

Continue Reading